Rosomni-Gold 75/75/20 vs 75/75/10, Rosomni-A and Rosomni-20

These two are the closest pair, and only one thing separates them.

Both are capsules containing Aspirin 75 mg and Clopidogrel 75 mg, so the antiplatelet cover is identical. The difference is the statin. Rosomni-Gold 75/75/20 contains rosuvastatin 20 mg, while Rosomni-Gold 75/75/10 contains rosuvastatin 10 mg.

A doctor generally selects the 20 mg version when a more intensive reduction in LDL cholesterol is wanted, for example when the LDL target set for that patient is a demanding one, when LDL has not fallen far enough on 10 mg, or when the overall risk profile calls for a stronger lipid effect from the outset.

The 10 mg version may suit someone whose LDL responds readily, someone who has had muscle symptoms at higher statin strengths, or someone in whom other factors make a gentler statin dose sensible. Neither is a stronger or weaker medicine overall; they are two settings of the same dial.

This comparison is about a missing molecule rather than a strength.

Rosomni-A 75/10 is a capsule of Aspirin Gastro-resistant and Rosuvastatin, containing Aspirin 75 mg and Rosuvastatin 10 mg. There is no clopidogrel in it. So it provides single antiplatelet cover plus moderate lipid lowering.

Rosomni-Gold 75/75/20 adds clopidogrel and doubles the statin strength. That makes it the more intensive option on both counts.

In practice, the two often sit at different points on the same patient journey. Dual antiplatelet therapy is typically used for a defined period after a stent or a heart attack. When that period ends and the cardiologist steps down to a single antiplatelet, a product without clopidogrel may become appropriate. That transition is a clinical decision made at a follow-up visit, never something a patient arranges at the chemist counter.

Rosomni-20 is Rosuvastatin Tablets IP 20 mg. It is a plain statin, with no antiplatelet component at all.

So the statin strength matches Rosomni-Gold 75/75/20 exactly, but everything else is different. Rosomni-20 suits a person who needs lipid lowering alone, for instance someone with high LDL and raised cardiovascular risk who has not had an event and for whom antiplatelet therapy is not indicated. Adding antiplatelet drugs to such a person would introduce bleeding risk without a matching reason.

It is also a useful comparison for understanding what the Gold capsule actually adds. The extra letters in the name are not a marketing upgrade; they represent two antiplatelet molecules with real effects and real risks. A capsule with more molecules in it is not automatically better for you. It is simply right for a different clinical situation.

Several threads come together in the decision.

Only your treating doctor sees all these threads at once, which is precisely why the choice belongs to them.

It is tempting to treat these four products as versions of one medicine, especially when a chemist has a related pack in stock and yours has run out. Please resist that.

Taking Rosomni-A 75/10 in place of Rosomni-Gold 75/75/20 would silently drop your clopidogrel, which after a recent stent can be genuinely dangerous. Taking Rosomni-20 instead would drop both antiplatelets. Moving from 20 mg to 10 mg of rosuvastatin without instruction may leave your LDL above the target your doctor set, and moving the other way adds statin exposure that was never assessed for you.

If your prescribed pack is unavailable, ask the chemist to order it, check another pharmacy, or call your doctor's clinic for guidance. Take a photograph of the strip so the person helping you can see the exact composition, and never accept a substitution simply because the names look similar.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.